Analysis of non-alcoholic fatty liver disease during induction therapy for B-cell precursor acute lymphoblastic leukemia in children and adolescents

A prospective evaluation of non-alcoholic fatty liver disease (NAFLD) during induction therapy for acute lymphoblastic leukemia (ALL) has not been performed. Herein, we prospectively investigated the frequency, risk factors, and outcomes of NAFLD during induction therapy in children and adolescents with B-cell precursor ALL (BCP-ALL).

Source: Pediatrics and Neonatology - July 14, 2023 Category: Perinatology & Neonatology Authors: Hirozumi Sano, Ryoji Kobayashi, Daisuke Suzuki, Masato Yanagi, Daiki Hori, Satoru Matsushima, Kunihiko Kobayashi Tags: Original Article Source Type: research